Dronabinol
Product Images NDC 60687-375

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dronabinol (NDC 60687-375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2.5 mg Dronabinol Capsule Blister 01.jpg

Dronabinal is a medication that comes in 25mg capsules. The text contains some errors that make it difficult to understand but it appears to reference two other medications, Cispluvex and Dronabinel. Some of the characters and symbols are not readable.*

FDA Label Image

2.5 mg Dronabinol Capsules Carton 01.jpg

Dronabinol Capsules, USP is a medication that comes in the form of 100 capsules (10 x 10) with each capsule containing 25mg of Dronabinol. It is a prescription-only drug and must be stored in a refrigerator at 2° to 8°C (36" to 45°F) to prevent freezing. The accompanying medication guide should be provided to each patient by the pharmacist. The package is from NDC # 42858-867, Rhodes Pharmaceuticals L.P., and distributed by American Health Packaging, Columbus, Ohio 43217, USA.*

FDA Label Image

5 mg Dronabinol Capsule Blister 01

The text is describing drug called Dronabinol also known as Dronatinal or Dronabinel. Different variants of the drug are mentioned as Dronabingl, Dronabinal, and ZIRRe. No further information about the drug is provided.*

FDA Label Image

5 mg Dronabinol Capsules Carton 01

This appears to be a label from a prescription medication called Dronabinol in capsule form. It includes information such as the drug's NDC code, dosage instructions, and storage requirements. The label also contains warnings about the importance of keeping the medication out of reach of children and not using it if the blister is damaged or torn. The medication was packaged and distributed by American Health Packaging in Ohio.*

FDA Label Image

Figure

The text is describing a study that measures appetite change using a visual analog scale (VAS). The study compares the effects of Dronabinol (at a dose of 2.5 mg twice daily) versus a placebo over several weeks. The asterisk indicates that the p-value for the comparison was less than 0.05, meaning that the difference between the two groups is statistically significant.*

FDA Label Image

Rhd08680

FDA Label Image

Rho08670

FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.